Merck

Novartis Said to Weigh Animal-Health Asset Swap
Bloomberg
Tue, 12/10/13 - 09:38 am
Novartis
animal health
Merck
Merck moves Alzheimer's drug into big trial after safety review
Yahoo/Reuters
Tue, 12/10/13 - 09:22 am
Merck
Alzheimer's disease
MK-8931
Merck agrees to settle litigation over Fosamax jaw injuries
Yahoo/Reuters
Mon, 12/9/13 - 03:24 pm
Merck
Fosamax
What Everybody Ought to Know About Gilead and Johnson & Johnson's New Hepatitis C Drugs
Seeking Alpha
Fri, 12/6/13 - 10:30 am
JNJ
Gilead Sciences
hepatitis C
sofosbuvir
Olysio
AbbVie
Bristol-Myers Squibb
Merck
Forest Laboratories: Merck's Saphris Acquisition Is A Good Move
Seeking Alpha
Thu, 12/5/13 - 06:44 pm
Merck
Forest Labs
Saphris
schizophrenia
The Future of Diabetes Control: Treat the Cause, Not the Symptom
Wall St Cheat Sheet
Thu, 12/5/13 - 10:04 am
diabetes
Novo Nordisk
Prandin
Merck
Lexicon Pharmaceuticals
LX4211
PAZ320
Boston Therapeutics
Four Ways Katie Couric Stacked The Deck Against Gardasil
Forbes
Thu, 12/5/13 - 08:29 am
Gardasil
Merck
HPV
vaccines
Cervarix
GSK
Forest to Acquire U.S. Marketing Rights to Saphris® (asenapine) from Merck
Yahoo
Mon, 12/2/13 - 10:17 am
Saphris
schizophrenia
Forest Labs
Merck
Merck's Noxafil Tablets Approved by the FDA
Yahoo/Zacks
Sat, 11/30/13 - 09:36 am
Merck
Noxafil
aspergillosis
Candida
Merck Gets FDA Approval for Noxafil Tablets, Increases Dividend
Motley Fool
Wed, 11/27/13 - 11:57 am
Merck
Noxafil
FDA
dividends
antifungals
Keep An Eye On GW, Johnson & Johnson, Durata, and Merck Today
Motley Fool
Wed, 11/27/13 - 09:58 am
JNJ
Durata Therapeutics
Merck
GW Pharma
Olysio
Savitex
Noxafil
Dalvance
Parental Attitudes on Sex, Costs Stymie HPV Vaccinations
Bloomberg
Tue, 11/26/13 - 08:55 am
HPV
vaccines
Cervarix
GSK
Merck
Gardasil
The Race For A Cure For Cancer
Seeking Alpha
Thu, 11/21/13 - 12:09 pm
cancer
Merck
Bristol-Myers Squibb
Roche
Peregrine Pharmaceuticals
Celgene Vs. Rivals In Psoriatic Arthritis Drug Race
Seeking Alpha
Wed, 11/20/13 - 08:29 am
psoriatic arthritis
Celgene
AbbVie
Amgen
JNJ
Merck
Humira
apremilast
Enbrel
Stelara
Simponi
Remicade
Keep an Eye on BioMarin, Amgen, Merck, and AstraZeneca Today
Motley Fool
Tue, 11/19/13 - 12:24 pm
Biomarin
Amgen
Merck
AstraZeneca
Merck Scores in Investigational Melanoma Study Results
Yahoo/Wall St 24-7
Mon, 11/18/13 - 04:33 pm
Merck
melanoma
MK-3475
Merck’s New Drug Application for an Investigational Intravenous (IV) Formulation of NOXAFIL® (posaconazole) Receives FDA Priority Review
Yahoo
Mon, 11/18/13 - 09:59 am
Merck
Noxafil
Aspergillus
Candida
FDA
Akorn Acquires U.S. Rights to Trio of Merck Eye Treatments
Motley Fool
Sat, 11/16/13 - 01:33 pm
Akorn
Merck
Azasite
Cosopt
Cosopt PF
Merck Raises 2013 Profit Forecast on Speed of Cost Cuts
Bloomberg
Thu, 11/14/13 - 12:10 pm
Merck
guidance
Merck May Lose Out From New Treatment Guide For Cholesterol
Seeking Alpha
Thu, 11/14/13 - 11:02 am
Merck
statins
cholesterol
Zetia

Pages